Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Ballantyne

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Journal of Cardiovascular Risk|December 29, 1998
Genetic and molecular markers for vascular disease. OverviewC M Ballantyne
The American Journal of Cardiology|November 18, 1998
Low-density lipoproteins and risk for coronary artery diseaseC M Ballantyne
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 27, 2000
Statins after cardiac transplantation: which statin, what dose, and how low should we go?C M Ballantyne
Clinical Cardiology|August 15, 2001
Newer risk markers and surrogate endpoints in atherosclerosis managementC M Ballantyne
The American Journal of Medicine|July 31, 1998
Current thinking in lipid loweringC M Ballantyne
The New England Journal of Medicine|February 8, 1996
Drugs in cardiac transplantationC M Ballantyne
The American Journal of Cardiology|October 10, 1998
Clinical trial endpoints: angiograms, events, and plaque instabilityC M Ballantyne
International Journal of Clinical Practice. Supplement|September 26, 2002
Familial hypercholesterolaemia: optimum treatment strategiesC M Ballantyne
The American Journal of Managed Care|June 1, 2001
Surrogate endpoints and newer risk markers in atherosclerosis managementC M Ballantyne
Circulation|September 26, 2001
September 11, 2001C M Ballantyne
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Journal of Cardiovascular Risk|December 29, 1998
Genetic and molecular markers for vascular disease. OverviewC M Ballantyne
The American Journal of Cardiology|November 18, 1998
Low-density lipoproteins and risk for coronary artery diseaseC M Ballantyne
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 27, 2000
Statins after cardiac transplantation: which statin, what dose, and how low should we go?C M Ballantyne
Clinical Cardiology|August 15, 2001
Newer risk markers and surrogate endpoints in atherosclerosis managementC M Ballantyne
The American Journal of Medicine|July 31, 1998
Current thinking in lipid loweringC M Ballantyne
The New England Journal of Medicine|February 8, 1996
Drugs in cardiac transplantationC M Ballantyne
The American Journal of Cardiology|October 10, 1998
Clinical trial endpoints: angiograms, events, and plaque instabilityC M Ballantyne
International Journal of Clinical Practice. Supplement|September 26, 2002
Familial hypercholesterolaemia: optimum treatment strategiesC M Ballantyne
The American Journal of Managed Care|June 1, 2001
Surrogate endpoints and newer risk markers in atherosclerosis managementC M Ballantyne
Circulation|September 26, 2001
September 11, 2001C M Ballantyne
Pageof 12